Pediatric Diabetes最新文献

{"title":"Burden of Treatment in Children and Adolescents With Type 1 Diabetes Evaluated by Focus Groups.","authors":"Sophie Le Fur, Iva Gueorguieva, Kevin Perge, Fatiha Guémazi, Nathalie Frament, Natacha Bouhours-Nouet, Berthe Razafimahefa, Pascale Trioche-Eberschweiler, Ramona Nicolescu, Patricia Pigeon-Kherchiche, Fabienne Dalla Vale, Claire Rodet, Alice Bonin, Nadège Bourvis, Pierre Bougnères","doi":"10.1155/pedi/8833434","DOIUrl":"https://doi.org/10.1155/pedi/8833434","url":null,"abstract":"<p><p><b>Objective:</b> Taking into account the burden of treatment (BOT) should favor psychological fulfillment and adherence of young patients to treatment, which largely determines the quality of type 1 diabetes (T1D) control. To identify BOT components, the Ariane study carried out a focus group survey among 84 children and adolescents with T1D aged 12.6 ± 3.7 years. <b>Research Design and Methods:</b> Focus groups were organized in 10 pediatric diabetes centers, a qualitative research method that brings together a small group of patients to express their perception of treatment and answer questions in a moderated nonmedical setting. <b>Results:</b> A total of 3640 verbatim voicing children's concerns were recorded, transcribed, and analyzed by five working groups composed of pediatric diabetologists, specialized nurses, adults with childhood-onset T1D, and two groups from the civil society. Each group studied the verbatim separately to extract 24 main concerns summarizing BOT. These concerns fell into two distinct categories: concerns about physical, material, and care organization (<i>N</i> = 15) or psychological concerns (<i>N</i> = 9). A BOT score summed the number of concerns of each patient. The mean BOT score was 7.4 ± 3.3 (range 1-18). Gender had a prominent influence on concerns (<i>p</i>=0.002). <b>Conclusions:</b> The identification of common concerns expressed through focus groups provides a new tool for estimation of BOT in childhood T1D.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"8833434"},"PeriodicalIF":3.9,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Taste Perception and Olfactory Function in Adolescents in Relation to the Duration of Type 1 Diabetes.","authors":"Grzegorz Sobek, Paweł Jagielski, Mariusz Dąbrowski, Artur Mazur","doi":"10.1155/pedi/5563863","DOIUrl":"10.1155/pedi/5563863","url":null,"abstract":"<p><p><b>Background:</b> Olfactory dysfunction may be one of the clinical symptoms of neuropathy in diabetics. It is also known that taste and smell disorders in diabetes may impact dietary adherence and, consequently, good glycemic control. The study aimed to investigate taste perception and olfactory function in adolescents with type 1 diabetes (T1D) compared to the control group. <b>Materials and Methods:</b> The study was conducted on patients aged 11-15 from south-eastern Poland with T1D in the diabetes clinic of the 2nd Department of Pediatrics, Endocrinology, and Diabetology of the Provincial Clinical Hospital No. 2 in Rzeszów. Taste strips (sweet, salty, sour, and bitter), <i>U</i>-Sniff sticks (12 selected smells), and a filter paper strip impregnated with n-propylthiouracil (PROP) were used. <b>Results:</b> No significant differences were observed between both the groups in the taste tests, except for the sweet taste test. The sweet taste test scores were higher for diabetes, for whom the median score was 4 (3.0-4.0), than for the control group, for whom the median score was 3.0 (3.0-4.0), (<i>p</i>=0.0001). These results mean that diabetics were more sensitive to sweet taste. We also found no significant differences between T1D and the control group of the <i>U</i>-Sniff test. However, significantly lower <i>U</i>-Sniff test scores were seen in adolescents with diabetes of more than 10 years. Median <i>U</i>-Sniff test scores for people with diabetes for 10 years were 11 (10.0-12.0) while in the control group median was 10.0 (9.0-12.0), (<i>p</i>=0.0370). The analysis also showed that adolescents suffering from long-term T1D more often incorrectly identified bitter tastes than healthy adolescents. <b>Conclusion:</b> The duration of diabetes is important regarding changes in taste perception and olfactory function in adolescents with diabetes.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"5563863"},"PeriodicalIF":3.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Equity of Continuous Glucose Monitoring in Children and Young People With Type 1 Diabetes: A Systematic Review.","authors":"James Howard Dicks, Lucy Jane McCann, Abraham Tolley, Alice Barrell, Lucy Johnson, Isla Kuhn, John Ford","doi":"10.1155/pedi/8875203","DOIUrl":"10.1155/pedi/8875203","url":null,"abstract":"<p><p><b>Background:</b> Socioeconomic status (SES) and ethnic inequalities in type 1 diabetes (T1D) outcomes are well-established. There is concern that unequal access to technologies, including continuous glucose monitoring (CGM), may increase disparities. This systematic review summarises the evidence for inequalities in the prevalence of CGM use for children and young people (CYP) and outcomes for CGM users. <b>Methods:</b> Medline, Embase and Web of Science were searched for observational studies published between January 2020 and July 2023 which report CGM use stratified by any PROGRESS-Plus criteria for T1D patients under 26. Reports based in low- or middle-income countries, ≤500 participants or only reporting hybrid closed-loop systems were excluded. Primary outcomes were the proportion of patients using CGM and HbA1c of CGM users. Quality assessment was performed using the Newcastle-Ottawa Scale. Unadjusted odds ratios were calculated from the extracted summary data, though heterogeneity precluded meta-analysis. The protocol was preregistered with PROSPERO (CRD42023438139). <b>Results:</b> Of the 3369 unique studies identified, 27 met the inclusion criteria. Thirty-three percent were of 'good' or 'very good' quality. We found decreased CGM use and higher discontinuation for low SES, low education, publicly insured and minority ethnic, especially Black, CYP. These associations were generally robust to adjustment for other sociodemographic variables, suggesting an independent effect. Lower SES inequalities were seen in countries where CGM is reimbursed. Although low SES and minority ethnicity were associated with poorer outcomes in general, for CGM users there was no significant association between domains of disadvantage and higher HbA1c, excepting parental education. <b>Conclusions:</b> There are significant SES, ethnic and education inequalities in CGM use for CYP with T1D, particularly when reimbursement is limited. This inequity is contributing to inequalities in T1D outcomes. However, evidence suggests CYP benefit equally from CGM use, irrespective of ethnicity and SES. Increasing CGM funding and use is likely to reduce outcome inequalities.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"8875203"},"PeriodicalIF":3.9,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12151618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Suicide Risk Screening in a Diverse Cohort of Youth With Type 1 and Type 2 Diabetes.","authors":"Saleel Fatima, Laura Prichett, Nancy Campbell, Meg C N Snyder, Morgan Bifano, Risa M Wolf","doi":"10.1155/pedi/6662248","DOIUrl":"10.1155/pedi/6662248","url":null,"abstract":"<p><p><b>Introduction:</b> Depression and suicide are more prevalent in adolescents with chronic illnesses such as diabetes. Psychosocial assessment is recommended in routine diabetes care. The goal of this study was to determine the prevalence of suicide risk in youth with diabetes and to determine the utility of the Patient Health Questionnaire-9 (PHQ-9) Item 9 compared to the Ask Suicide-Screening Questions (ASQ). <b>Methods:</b> The PHQ-9 and ASQ were prospectively administered to patients with type 1 diabetes (T1D) and type 2 diabetes (T2D), ages 11-24 years at routine diabetes visits at a pediatric diabetes center from January to December 2023. Depression and suicide risk were assessed using PHQ-9 Item 9 and ASQ. The sensitivity and specificity of PHQ-9 were determined using ASQ as the reference standard. <b>Results:</b> Among the 309 patients included in this study, 237 (76.6%) had T1D and 72 (23.3%) had T2D. The mean age was 15.1 ± 2.6 years, 145 (46.9%) were female, and the mean HbA1c was 8.6% ± 2.3%. The prevalence of suicide risk using PHQ-9 Item 9 was 5.9% in T1D and 12.5% in T2D, and 8.4% in T1D and 19.4% in T2D, using ASQ. The sensitivity of the PHQ-9 Item 9 was 55.9% (95% CI: 37.9, 72.8%), specificity was 98.5% (95% CI: 96.3, 99.6%), PPV was 82.6% (95% CI: 61.2, 95%), and NPV was 94.8% (95% CI: 91.5, 97%) as compared to ASQ as reference standard. After a positive suicide risk screen, only 52.9% completed mental health follow-up at 1 month. The feasibility survey showed providers could identify high risk patients without workflow impact. <b>Conclusion:</b> Prevalence of suicide risk is higher in youth with T2D compared to T1D. PHQ-9 is less sensitive in identifying suicide risk in adolescents and young adults (AYA) compared to the ASQ. Diabetes care teams should consider using a specific suicide risk screener in routine diabetes care. Follow-up with mental health is suboptimal, and should be encouraged.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"6662248"},"PeriodicalIF":3.9,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Etiologic Determinants and Characteristics of Diabetes in Haitian Youth (EDDHY Study).","authors":"Eddy Jean-Baptiste, Philippe Larco, Julia E Von Oettingen, Janelle A Noble, Steven J Mack, Ningyi Song, Harper R N Martin, Erik Rozemuller, Mark A Atkinson, Denira Govender, Nancy Charles Larco, Graham D Ogle","doi":"10.1155/pedi/9974561","DOIUrl":"10.1155/pedi/9974561","url":null,"abstract":"<p><p><b>Aims:</b> Published information on youth-onset diabetes in Haiti is scarce, with limited data available on diabetes autoimmunity and genetic susceptibility to the disease. We determined the anthropometric, metabolic, and immunological characteristics and human leukocyte antigen (HLA)-associated risks in patients with youth-onset diabetes. <b>Methods:</b> One hundred and ten subjects with type 1 diabetes (T1D) aged <22 years and diagnosed for < 2 years were evaluated. Demographic and clinical information, as well as biochemical parameters, including blood glucose, hemoglobin A1c, fasting C-peptide (FCP), and T1D-associated autoantibodies, were assessed. DNA from 54 subjects and 66 controls was genotyped for classical HLA loci. <b>Results:</b> Of the 110 patients, 54% were male. Onset age was 13.5 ± 4.2 years (range 2-21), and disease duration was 11.7 ± 8.1 months (range 0-24). Idiopathic T1D was found in 62 (56.4%) patients and was diagnosed at an older age than immune-mediated T1D (14.4 ± 3.5 years vs., 12.3 ± 4.8 years, <i>p</i>=0.01), with a higher BMI z-score in patients aged <14 years than in those aged ≥14 years (-0.29 ± 1.52 vs., -1.15 ± 1.18, <i>p</i>=0.01). No correlation was found between immune-mediated T1D and BMI z-score. Diabetic ketoacidosis was present at diagnosis in 18 (16.4%) patients. Zinc transporter 8 autoantibodies (ZnT8A) were marginally more common in younger patients. Low FCP levels were found in 71 (64.5%) patients. Thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TG-Ab) were positive in 1.1% and 2.2% of the patients, respectively. The alleles <i>DRB1⁣</i> ^<i>∗</i> <i>03:01</i>, <i>DRB1⁣</i> ^<i>∗</i> <i>09:01</i>, <i>DQB1⁣</i> ^<i>∗</i> <i>02:01</i>, and <i>DQB1⁣</i> ^<i>∗</i> <i>02:02</i> showed a significant T1D risk, whereas <i>DRB1⁣</i> ^<i>∗</i> <i>08:04</i>, <i>DRB1⁣</i> ^<i>∗</i> <i>15:03</i>, and <i>DQB1⁣</i> ^<i>∗</i> <i>06:02</i> were protective. Three <i>DRB1~DQB1</i> haplotypes were strongly associated with T1D: <i>DRB1⁣</i> ^<i>∗</i> <i>03:01:01~DQB1⁣</i> ^<i>∗</i> <i>02:01:01</i>, <i>DRB1⁣</i> ^<i>∗</i> <i>09:01:02~DQB1⁣</i> ^<i>∗</i> <i>02:02:01</i>, both predisposing, and <i>DRB1⁣</i> ^<i>∗</i> <i>15:03:01~DQB1⁣</i> ^<i>∗</i> <i>06:02:01</i>, <i>protective</i>. <b>Conclusions:</b> Idiopathic T1D is common among youth in Haiti. A significant proportion of all patients had preserved C-peptide secretion. Overall, predisposing and protective HLA patterns were identified. Study results highlight the importance of distinguishing T1D endotypes within and between populations.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"9974561"},"PeriodicalIF":3.9,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12127126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic-Results From the DPV Registry.","authors":"Valentina Lahn, Sascha R Tittel, Ute Ohlenschläger, Clemens Kamrath, Johanna Hammersen, Renata Gellai, Kirsten Mönkemöller, Axel Dost, Heike Bartelt, Reinhard W Holl","doi":"10.1155/pedi/9903467","DOIUrl":"10.1155/pedi/9903467","url":null,"abstract":"<p><p>To investigate whether the remission period in type 1 diabetes, as measured by insulin-dose adjusted A1c (IDAA1C), was affected by the COVID-19 pandemic. Data from 7603 children and adolescents with type 1 diabetes from the prospective diabetes follow-up (DPV) registry were available. We compared two time periods of diabetes onset, 2020/2021 vs. 2018/2019. IDAA1C and remission prevalence (IDAA1c < 9%) were analyzed using logistic and linear regression models adjusted for age groups (0.5-<6, 6-<12, and 12-<18 years), sex, diabetic ketoacidosis (DKA) at onset, use of continuous glucose monitoring (CGM) systems, insulin pumps, sensor-augmented pumps (SAPs) or automated insulin delivery (AID) systems, BMI categories (<90. percentile of BMI, 90. -<97. percentile of BMI, 97. -<99.5 percentile of BMI, > = 99.5 percentile of BMI) and immigrant background. Data from three time periods were analyzed: 3-5 months, 6-10 months, and 11-13 months after diagnosis of type 1 diabetes. Compared to the prepandemic period, during the COVID-19 pandemic adjusted IDAA1C was significantly higher at 3-5 months after diagnosis (mean estimated differences 0.26 [95% confidence interval 0.17; 0.35], <i>p</i>  < 0.001), but not at 6-10 months and 11-13 months after diagnosis (mean estimated difference 0.08 [-0.01; 0.17], <i>p</i>=0.07; and -0.03 [-0.12; 0.07], <i>p</i>=0.60), reflecting a lower percentage of patients in remission at 3-5 months. Reasons may be changes in autoimmune progression during the pandemic, lack of physical activities, increased stress or psychological burden, or altered access to care with delayed diagnosis of diabetes. Underlying causes need to be evaluated in future studies.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"9903467"},"PeriodicalIF":3.9,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144128040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Markers of Early Liver Dysfunction Associate With Reduced Heart Rate Variability in Adolescents With Type 1 Diabetes.","authors":"Vallimayil Velayutham, Paul Z Benitez-Aguirre, Gerald Liew, Alicia J Jenkins, Maria E Craig, Kim C Donaghue","doi":"10.1155/pedi/1910554","DOIUrl":"10.1155/pedi/1910554","url":null,"abstract":"<p><p><b>Aim:</b> Data on the impact of metabolic dysfunction-associated fatty liver disease (MAFLD) on diabetes complications in youth with type 1 diabetes are lacking. However, MAFLD is well known to contribute to cardiovascular disease (CVD) in people with type 2 diabetes. We aimed to investigate markers of MAFLD in youth with type 1 diabetes and their relationship with chronic complications. <b>Methods:</b> A prospective study of 102 adolescents (mean age 14.7 ± 1.9 years) with type 1 diabetes underwent repeated annual diabetes complications assessments, including annual measures of liver enzymes. Early cardiac autonomic nerve dysfunction (CAN) was defined as ≥1 abnormality in seven heart rate variability parameters derived from a 10-min resting electrocardiogram. Multivariate generalized estimating equations explored predictors of CAN and other microvascular complications (retinopathy and early kidney dysfunction). <b>Results:</b> After a median follow-up of 3.5 years (IQR 2.7-4.6), there were significant increases in the mean alanine transaminase level (ALT) and systolic blood pressure (SBP) percentiles. Upper ALT and gamma-glutamyl transferase (GGT) tertiles (T3 vs. T1-2: odds ratio [OR], 95% confidence interval [CI], 2.05 [1.20, 3.48], and 2.99 [1.61, 5.58], respectively) predicted CAN development (23%, <i>n</i> = 24) independent of HbA1c and diabetes duration. They were not associated with retinopathy or early kidney dysfunction. <b>Conclusion:</b> Higher ALT and GGT associate with early CAN in adolescents with type 1 diabetes, suggesting hepatic inflammation may compound the impact of the diabetes milieu on systemic endothelial dysfunction.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"1910554"},"PeriodicalIF":3.9,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in Prevalence of Insulin Resistance Among Nondiabetic/Nonprediabetic Adolescents, 1999-2020.","authors":"Dongying Zhao, Liwei Wang, Xianting Jiao, Chutian Shi, Zhongcheng Luo, Yan Chen, Yongjun Zhang","doi":"10.1155/pedi/9982025","DOIUrl":"10.1155/pedi/9982025","url":null,"abstract":"<p><p><b>Purpose:</b> Insulin resistance (IR)/hyperinsulinemia in young individuals is associated with the subsequent development of diabetes and cardiovascular disease. To assess trends in the prevalence of IR/hyperinsulinemia among nondiabetic/nonprediabetic adolescents in the US from 1999 to 2020. <b>Methods:</b> A total of 6111 adolescents without diabetes and prediabetes were included from ten cycles of National Health and Nutrition Examination Survey (NHANES) between 1999-2000 and 2017-2020. Hyperinsulinemia or IR was defined as fasting insulin or homeostasis model assessment of insulin resistance [HOMA-IR] above the 75th percentile in all participants who underwent blood tests on fasting insulin, glucose, and hemoglobin A1c. Trends in prevalence rates were estimated using joinpoint regressions with heteroscedastic and uncorrelated errors. <b>Results:</b> The overall weighted median fasting insulin level, prevalence of hyperinsulinemia, and IR were 9.9 μU/ml [95% confidence interval (CI): 9.6, 10.1], 17.2% (95% CI: 15.7, 18.6), and 16.4% (95% CI: 15.2, 17.9), respectively. The estimated prevalence of hyperinsulinemia and HOMA-IR increased significantly from 15.2% (95% CI: 12.1, 18.9) and 14.0% (95% CI: 11.1, 17.8) in 1999-2000% to 21.5% (95% CI: 17.1, 26.3) and 20.4% (95% CI: 16.4, 25.6) in 2017-2020, respectively, with a 3.35% (95% CI: 1.74, 4.99) and 3.41% (95% CI: 1.72, 5.12) relative increase per 2-year survey cycle, respectively (<i>p</i> for trend <0.05). Substantial increases were observed in the subgroups of girls, Hispanic, non-Hispanic white, and overweight adolescents. <b>Conclusions:</b> The prevalence of hyperinsulinemia/IR increased substantially among US nondiabetic/nonprediabetic adolescents over the last two decades. Early detection and effective interventions are in dire need to reverse the rising tide.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"9982025"},"PeriodicalIF":3.9,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144005115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Positive Impact of a Specialized Summer Camp on the Correlation Between Improved Mental Health and Glycemic Control in Pediatric Type 1 Diabetic Patients.","authors":"Lauren McManus, Colby Vinson, Dharak Patel, Casey Faichtinger, Zakariya Yazdani, Rikki Ray, Rhadika Patel, Matthew Stokell, Brooke Birks, Lesley A Gardiner, Petra Rocic","doi":"10.1155/pedi/4811222","DOIUrl":"https://doi.org/10.1155/pedi/4811222","url":null,"abstract":"<p><p>Type 1 diabetes mellitus (T1DM) is associated with an increased risk of mental illness. In recent years, specialized summer camps for children and adolescents with type 1 diabetes have emerged, aimed at normalizing life with diabetes and building skills needed for optimal management of the condition. This project analyzed the effects of one such camp, Camp Sweeney, on glycemic control, physical health, and psychosocial wellbeing of camp attendees (children 5-17, mean age 14.4 years old) and their parents/caregivers. The standard Pediatric Quality of Life Inventory (PedsQL) was modified by the addition of questions pertaining to self-assessment of diabetes management, and questionnaires were distributed to parents and campers to complete at the start of and 2 months after completion of the camp. A total of 14 completed surveys (7 child/camper-parent/caregiver pairs) were collected and analyzed. Self-reported glycemic control (DM management), perceived overall quality of life (wellness), physical wellness, and psychosocial wellness improved after attendance of Camp Sweeney as reported by both campers/children (<i>Δ</i>17.86% DM management, <i>Δ</i>10.96% overall wellness, <i>Δ</i>16.25% psychosocial wellness) and their parents/caregivers (<i>Δ</i>16.07% DM management, <i>Δ</i>14.54% overall wellness, <i>Δ</i>17.86% psychosocial wellness). Importantly, we established a significant positive correlation between glycemic control (DM management) and overall wellness, psychosocial wellness, and average quality of life (correlation coefficient = 0.92, 0.80, and 0.94, respectively). While previous studies do provide some evidence that these types of camps improve the mental wellbeing of participants, this is the first study to establish a direct correlation between improved mental and psychosocial wellbeing and diabetes management.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"4811222"},"PeriodicalIF":3.9,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144037631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Executive Functioning, Diabetes Distress, and Diabetes Management Among Adolescents With Type 1 Diabetes: Youth and Parent Perspectives.","authors":"Allison Choe, Emily M Fredericks, Dana Albright, Joyce M Lee, Julie M Sturza, Hurley O Riley, Niko Kaciroti, Katherine W Bauer, Alison L Miller","doi":"10.1155/pedi/7036544","DOIUrl":"10.1155/pedi/7036544","url":null,"abstract":"<p><p><b>Objective:</b> Most adolescents with Type 1 Diabetes (T1D) do not achieve recommended glycemic targets, placing them at risk for long-term complications. Executive functioning (EF), or the cognitive processes that support goal-directed action and management of behavior, emotion, and cognition, is proposed to support effective T1D management and contribute to glycemic stability. We sought to examine associations of EF with T1D management behaviors and diabetes-related distress in adolescents with T1D. <b>Methods:</b> Participants were 13-17-year-olds (<i>M</i> = 15.44, <i>SD</i> = 1.38 years) from a randomized controlled trial (<i>N</i> = 88). We conducted secondary analyses of preintervention data. Youth and their parents each reported on youth EF (Behavior Rating Inventory of Executive Functioning; BRIEF) and T1D management behaviors (Self-Care Inventory-Revised; SCI-R), parents reported on responsibility for T1D management (Diabetes Family Responsibility Questionnaire; DFRQ), and youth reported on their diabetes-related distress (Problem Areas In Diabetes-Teen; PAID-T). Youth also completed performance-based measures of EF. <b>Results:</b> Questionnaire-based and performance-based EF measures were generally unrelated. Regression analysis showed that youth self-reported EF predicted youth-reported T1D management (SCI-R) and diabetes distress (PAID-T) outcomes, and parent-reported youth EF predicted parent-reported T1D management behaviors, such that greater EF difficulties predicted suboptimal management and greater diabetes-related distress (youth PAID-T <i>β</i>: 0.41, <i>p</i>  < 0.01; youth SCI-R <i>β</i>: -0.40, <i>p</i>  < 0.01; parent SCI-R <i>β:</i> -0.33, <i>p</i>  < 0.01). Older child age and poorer performance-based EF also predicted greater youth responsibility for T1D management (age <i>β</i>: 0.43,<i>p</i>  < 0.01; EF reaction time <i>β</i>: 0.23,<i>p</i> < 0.05; EF accuracy <i>β</i>: -0.23, <i>p</i> < 0.05). <b>Conclusions:</b> Youth EF may shape which adolescents are at increased risk for suboptimal T1D management as well as diabetes distress; understanding EF challenges may help guide T1D family management across this developmental period. Implications for EF measurement approaches in youth are also discussed. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT03688919.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"7036544"},"PeriodicalIF":3.9,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12016923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}